CLCN7 | Chloride channel, voltage-sensitive 7 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
LETM1 | Leucine zipper-EF-hand containing transmembrane protein 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MPC1 | Mitochondrial pyruvate carrier 1 | Disease related genes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SFXN4 | Sideroflexin 4 | Disease related genes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC12A3 | Solute carrier family 12 (sodium/chloride transporter), member 3 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC12A5 | Solute carrier family 12 (potassium/chloride transporter), member 5 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC13A3 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC17A6 | Solute carrier family 17 (vesicular glutamate transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC17A7 | Solute carrier family 17 (vesicular glutamate transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC1A2 | Solute carrier family 1 (glial high affinity glutamate transporter), member 2 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC1A3 | Solute carrier family 1 (glial high affinity glutamate transporter), member 3 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC1A5 | Solute carrier family 1 (neutral amino acid transporter), member 5 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC1A6 | Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC22A12 | Solute carrier family 22 (organic anion/urate transporter), member 12 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A13 | Solute carrier family 22 (organic anion/urate transporter), member 13 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A15 | Solute carrier family 22, member 15 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC22A2 | Solute carrier family 22 (organic cation transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A8 | Solute carrier family 22 (organic anion transporter), member 8 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC23A1 | Solute carrier family 23 (ascorbic acid transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC25A10 | Solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC25A12 | Solute carrier family 25 (aspartate/glutamate carrier), member 12 | Disease related genes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Transporters
| | | | | Expressed in all |
SLC25A26 | Solute carrier family 25 (S-adenosylmethionine carrier), member 26 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC26A2 | Solute carrier family 26 (anion exchanger), member 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC28A2 | Solute carrier family 28 (concentrative nucleoside transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A14 | Solute carrier family 2 (facilitated glucose transporter), member 14 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC2A2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC32A1 | Solute carrier family 32 (GABA vesicular transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC34A2 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 2 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC34A3 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC35C1 | Solute carrier family 35 (GDP-fucose transporter), member C1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC36A2 | Solute carrier family 36 (proton/amino acid symporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC37A1 | Solute carrier family 37 (glucose-6-phosphate transporter), member 1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC38A10 | Solute carrier family 38, member 10 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC43A1 | Solute carrier family 43 (amino acid system L transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC44A4 | Solute carrier family 44, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
SLC45A3 | Solute carrier family 45, member 3 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC4A1 | Solute carrier family 4 (anion exchanger), member 1 (Diego blood group) | Blood group antigen proteins CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC4A10 | Solute carrier family 4, sodium bicarbonate transporter, member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC4A2 | Solute carrier family 4 (anion exchanger), member 2 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC4A4 | Solute carrier family 4 (sodium bicarbonate cotransporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC4A7 | Solute carrier family 4, sodium bicarbonate cotransporter, member 7 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC51B | Solute carrier family 51, beta subunit | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC5A1 | Solute carrier family 5 (sodium/glucose cotransporter), member 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |